Stockreport

Early-stage study underway assessing Nantkwest's HER2.taNK in brain cancer; shares up 2% [Seeking Alpha]

NANTKWEST  (NK) 
Last nantkwest earnings: 3/25 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nantkwest.com
PDF Early-stage study underway assessing Nantkwest's HER2.taNK in brain cancer; shares up 2%Thefirst patient has been dosed in aPhase 1 clinical trial evaluating NantKwest's [Read more]